SeaCrest Wealth Management LLC increased its stake in shares of Clorox Co (NYSE:CLX) by 85.7% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,489 shares of the company’s stock after acquiring an additional 1,610 shares during the period. SeaCrest Wealth Management LLC’s holdings in Clorox were worth $536,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of the stock. State Street Corp lifted its stake in Clorox by 2.6% in the 3rd quarter. State Street Corp now owns 8,336,740 shares of the company’s stock valued at $1,266,101,000 after purchasing an additional 207,856 shares during the last quarter. Parnassus Investments CA lifted its stake in Clorox by 0.4% in the 3rd quarter. Parnassus Investments CA now owns 4,651,499 shares of the company’s stock valued at $706,423,000 after purchasing an additional 17,409 shares during the last quarter. California Public Employees Retirement System lifted its stake in Clorox by 7.7% in the 3rd quarter. California Public Employees Retirement System now owns 1,040,151 shares of the company’s stock valued at $157,968,000 after purchasing an additional 74,260 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its stake in Clorox by 8.8% in the 2nd quarter. Price T Rowe Associates Inc. MD now owns 632,461 shares of the company’s stock valued at $96,836,000 after purchasing an additional 51,252 shares during the last quarter. Finally, Parametric Portfolio Associates LLC lifted its stake in Clorox by 1.3% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 617,126 shares of the company’s stock valued at $93,723,000 after purchasing an additional 7,673 shares during the last quarter. Institutional investors and hedge funds own 77.94% of the company’s stock.
Several equities research analysts recently issued reports on the stock. Barclays set a $138.00 target price on shares of Clorox and gave the company a “sell” rating in a research note on Friday, November 1st. Citigroup dropped their target price on Clorox from $167.00 to $163.00 and set a “neutral” rating for the company in a report on Thursday, October 3rd. Deutsche Bank boosted their target price on shares of Clorox from $145.00 to $147.00 and gave the company a “hold” rating in a research report on Thursday, December 12th. Morgan Stanley restated an “underweight” rating and issued a $134.00 price target (down from $144.00) on shares of Clorox in a research note on Monday, September 30th. Finally, Bank of America lowered their price target on shares of Clorox from $165.00 to $160.00 and set a “neutral” rating on the stock in a research report on Thursday, October 3rd. Five research analysts have rated the stock with a sell rating, eight have issued a hold rating and two have assigned a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and a consensus price target of $152.17.
Clorox (NYSE:CLX) last posted its quarterly earnings results on Thursday, October 31st. The company reported $1.59 EPS for the quarter, beating the Zacks’ consensus estimate of $1.54 by $0.05. The business had revenue of $1.51 billion during the quarter, compared to the consensus estimate of $1.51 billion. Clorox had a return on equity of 123.56% and a net margin of 13.20%. Clorox’s revenue for the quarter was down 3.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.62 earnings per share. On average, research analysts predict that Clorox Co will post 6.14 earnings per share for the current fiscal year.
The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be issued a dividend of $1.06 per share. This represents a $4.24 dividend on an annualized basis and a dividend yield of 2.67%. The ex-dividend date of this dividend is Tuesday, January 28th. Clorox’s dividend payout ratio (DPR) is presently 67.09%.
In related news, SVP Denise Garner sold 725 shares of the company’s stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $146.34, for a total transaction of $106,096.50. Following the completion of the sale, the senior vice president now directly owns 5,805 shares in the company, valued at approximately $849,503.70. The sale was disclosed in a filing with the SEC, which is available through this link. Also, SVP Andrew J. Mowery sold 5,648 shares of the firm’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $146.29, for a total value of $826,245.92. Following the completion of the sale, the senior vice president now directly owns 15,920 shares in the company, valued at $2,328,936.80. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Cleaning, Household, Lifestyle, and International. The company offers laundry additives, including bleach products under the Clorox brand, as well as Clorox 2 stain fighter and color booster; home care products primarily under the Clorox, Formula 409, Liquid-Plumr, Pine-Sol, S.O.S, and Tilex brands; naturally derived products under the Green Works brand; and professional cleaning, disinfecting, and food service products under the Clorox, Dispatch, HealthLink, Clorox Healthcare, Hidden Valley, KC Masterpiece, and Soy Vay brands.
Featured Article: Compound Annual Growth Rate (CAGR)
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.